Matches in Wikidata for { <http://www.wikidata.org/entity/Q80118700> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q80118700 description "artículu científicu espublizáu en setiembre de 2006" @default.
- Q80118700 description "im September 2006 veröffentlichter wissenschaftlicher Artikel" @default.
- Q80118700 description "scientific article published on 01 September 2006" @default.
- Q80118700 description "wetenschappelijk artikel" @default.
- Q80118700 description "наукова стаття, опублікована у вересні 2006" @default.
- Q80118700 name "Novel treatment of Sézary-like syndrome due to adult T-cell leukaemia/lymphoma with daclizumab (humanized anti-interleukin-2 receptor alpha antibody)" @default.
- Q80118700 name "Novel treatment of Sézary-like syndrome due to adult T-cell leukaemia/lymphoma with daclizumab (humanized anti-interleukin-2 receptor alpha antibody)" @default.
- Q80118700 type Item @default.
- Q80118700 label "Novel treatment of Sézary-like syndrome due to adult T-cell leukaemia/lymphoma with daclizumab (humanized anti-interleukin-2 receptor alpha antibody)" @default.
- Q80118700 label "Novel treatment of Sézary-like syndrome due to adult T-cell leukaemia/lymphoma with daclizumab (humanized anti-interleukin-2 receptor alpha antibody)" @default.
- Q80118700 prefLabel "Novel treatment of Sézary-like syndrome due to adult T-cell leukaemia/lymphoma with daclizumab (humanized anti-interleukin-2 receptor alpha antibody)" @default.
- Q80118700 prefLabel "Novel treatment of Sézary-like syndrome due to adult T-cell leukaemia/lymphoma with daclizumab (humanized anti-interleukin-2 receptor alpha antibody)" @default.
- Q80118700 P1433 Q80118700-10A51BB1-14AB-42A3-9EF3-FC2D2469CD36 @default.
- Q80118700 P1476 Q80118700-C350C016-9967-436C-A470-A25B77269BCE @default.
- Q80118700 P2093 Q80118700-097D24DD-3A2C-4555-B9DE-8F2E271E9AEE @default.
- Q80118700 P2093 Q80118700-8DB74B4E-5DC5-458F-91CA-1BCB1C7D5C20 @default.
- Q80118700 P2093 Q80118700-DA0E5ADD-811C-432C-A15C-5ADAE59938B9 @default.
- Q80118700 P304 Q80118700-1118C907-8AAB-43B5-8732-F782FC6FB999 @default.
- Q80118700 P31 Q80118700-235C652F-6ACE-4A86-9A80-BACBE0D83B68 @default.
- Q80118700 P356 Q80118700-353E19D8-EE72-416A-91E7-7A877C35ED13 @default.
- Q80118700 P407 Q80118700-252903D8-C552-44F6-BF2D-3C3246E8AAC8 @default.
- Q80118700 P433 Q80118700-936CF7C9-CE6A-41DF-8740-BAFF3FFFE60D @default.
- Q80118700 P478 Q80118700-D7FDEBF0-5F50-4F1A-BDBD-E25C375362F0 @default.
- Q80118700 P50 Q80118700-CA16B4E6-B4EB-475D-B52D-25B3DF32386C @default.
- Q80118700 P577 Q80118700-3A18A243-F260-47D8-9CD6-3BACF63F0ABA @default.
- Q80118700 P698 Q80118700-35552ACB-528D-4309-9F0D-F72E31AAA42D @default.
- Q80118700 P356 J.1365-2133.2006.07355.X @default.
- Q80118700 P698 16911291 @default.
- Q80118700 P1433 Q4970191 @default.
- Q80118700 P1476 "Novel treatment of Sézary-like syndrome due to adult T-cell leukaemia/lymphoma with daclizumab (humanized anti-interleukin-2 receptor alpha antibody)" @default.
- Q80118700 P2093 "Ho A" @default.
- Q80118700 P2093 "Osborne GE" @default.
- Q80118700 P2093 "du Vivier AW" @default.
- Q80118700 P304 "617-620" @default.
- Q80118700 P31 Q13442814 @default.
- Q80118700 P356 "10.1111/J.1365-2133.2006.07355.X" @default.
- Q80118700 P407 Q1860 @default.
- Q80118700 P433 "3" @default.
- Q80118700 P478 "155" @default.
- Q80118700 P50 Q56587807 @default.
- Q80118700 P577 "2006-09-01T00:00:00Z" @default.
- Q80118700 P698 "16911291" @default.